Trib3 was shown to enhance the tumorigenicity of a variety of tumor cell lines and xenografts via a mechanism that involved dysregulation of AKT phosphorylation by the mTORC2 complex and subsequent inactivation of the transcription factor FOXO3 [44]. The gene discussed is TRIB3; the disease is neoplasm.